Novo Nordisk Investigational Site

Copenhagen 2400

0 studies enrolling now · 7 studies all time

What they study most

Acquired Bleeding Disorder, Bleeding During/Following Surgery, Chronic Kidney Disease, Congenital Bleeding Disorder, Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, End-Stage Renal Disease, Haemophilia A, Haemophilia B, Intracerebral Haemorrhage

Studies at this site

• Safety and Efficacy of Turoctocog Alfa in Haemophilia A Subjects — Completed
• The Effect of Somatropin Treatment in Adult Patients on Chronic Dialysis — Stopped early
• The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes — Completed
• Comparison of Insulin Detemir Morning, Insulin Detemir Evening and NPH Insulin Evening in Patients With Type 2 Diabetes — Completed
• Safety of 40K Pegylated Recombinant Factor IX in Non-Bleeding Patients With Haemophilia B — Completed
• Recombinant Factor VIIa in Acute Intracerebral Haemorrhage — Completed
• Efficacy and Safety of Activated Recombinant Human Factor VII in Treatment of Bleeding in Patients Following Allogeneic Stem Cell Transplantation — Completed